Blanca Cucarull

438 total citations
10 papers, 330 citations indexed

About

Blanca Cucarull is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Blanca Cucarull has authored 10 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Hepatology. Recurrent topics in Blanca Cucarull's work include Cancer Mechanisms and Therapy (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Liver physiology and pathology (3 papers). Blanca Cucarull is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Liver physiology and pathology (3 papers). Blanca Cucarull collaborates with scholars based in Spain, United States and Norway. Blanca Cucarull's co-authors include Montserrat Marı́, Albert Morales, Anna Tutusaus, Anna Colell, Estefanía de Gregorio, Pablo Garcı́a de Frutos, Vicente Roca‐Agujetas, Cristina de Dios, María Reig and Milica Stefanović and has published in prestigious journals such as Journal of Hepatology, Oncotarget and Biochimie.

In The Last Decade

Blanca Cucarull

10 papers receiving 329 citations

Peers

Blanca Cucarull
Fatima Rizvi United States
Sumin Sun China
Blanca Cucarull
Citations per year, relative to Blanca Cucarull Blanca Cucarull (= 1×) peers Noha A. Amin

Countries citing papers authored by Blanca Cucarull

Since Specialization
Citations

This map shows the geographic impact of Blanca Cucarull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blanca Cucarull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blanca Cucarull more than expected).

Fields of papers citing papers by Blanca Cucarull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blanca Cucarull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blanca Cucarull. The network helps show where Blanca Cucarull may publish in the future.

Co-authorship network of co-authors of Blanca Cucarull

This figure shows the co-authorship network connecting the top 25 collaborators of Blanca Cucarull. A scholar is included among the top collaborators of Blanca Cucarull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blanca Cucarull. Blanca Cucarull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cucarull, Blanca, Anna Tutusaus, Pablo Garcı́a de Frutos, et al.. (2022). Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances. Cancers. 14(3). 621–621. 49 indexed citations
2.
Tutusaus, Anna, Blanca Cucarull, Pablo Garcı́a de Frutos, et al.. (2022). Mitochondrial damage, revealed as key factor in cabozantinib efficacy against hepatocellular carcinoma, is potentiated by the BH3-mimetic navitoclax. Journal of Hepatology. 77. S652–S652. 1 indexed citations
3.
Cucarull, Blanca, Anna Tutusaus, Pablo Garcı́a de Frutos, et al.. (2021). Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species. Antioxidants. 10(9). 1336–1336. 17 indexed citations
4.
Marı́, Montserrat, Estefanía de Gregorio, Cristina de Dios, et al.. (2020). Mitochondrial Glutathione: Recent Insights and Role in Disease. Antioxidants. 9(10). 909–909. 126 indexed citations
5.
Cucarull, Blanca, Anna Tutusaus, Milica Stefanović, et al.. (2020). Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models. Cancers. 12(2). 332–332. 22 indexed citations
6.
Tutusaus, Anna, Estefanía de Gregorio, Blanca Cucarull, et al.. (2019). A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Cellular and Molecular Gastroenterology and Hepatology. 9(3). 349–368. 50 indexed citations
7.
Tutusaus, Anna, Milica Stefanović, Loreto Boix, et al.. (2018). Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma. Oncotarget. 9(24). 16701–16717. 48 indexed citations
8.
Tutusaus, Anna, Mario Štefanović, Blanca Cucarull, et al.. (2018). Sorafenib/Regorafenib resistance and BH3-mimetics efficacy in hepatocellular carcinoma treatment is determined by mitochondrial changes in the BCL-2 profile. Journal of Hepatology. 68. S686–S687. 1 indexed citations
9.
Tutusaus, Anna, et al.. (2018). AXL increase in NASH patients and anti-fibrotic efficacy of AXL inhibition in experimental NASH. Journal of Hepatology. 68. S394–S394. 1 indexed citations
10.
Mateu-Jiménez, Mercè, Blanca Cucarull, José Yélamos, & Esther Barreiro. (2015). Reduced tumor burden through increased oxidative stress in lung adenocarcinoma cells of PARP-1 and PARP-2 knockout mice. Biochimie. 121. 278–286. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026